Last $7.69 USD
Change Today -0.46 / -5.64%
Volume 1.6M
ONVO On Other Exchanges
As of 8:04 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

organovo holdings inc (ONVO) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/18/13 - $13.65
52 Week Low
08/2/13 - $4.43
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ORGANOVO HOLDINGS INC (ONVO)

organovo holdings inc (ONVO) Related Bloomberg News

View More Bloomberg News

organovo holdings inc (ONVO) Related Businessweek News

View More BusinessWeek News

organovo holdings inc (ONVO) Details

Organovo Holdings, Inc., a development-stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease, for use in drug discovery and development; and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting and nerve grafts for nerve damage repair, as well as functional tissue patches for the repair or replacement of damaged tissues and organs. Organovo Holdings, Inc. has collaboration agreements with United Therapeutics Corporation; Knight Cancer Institute at Oregon Health & Science University; Michael J. Fox Foundation; Hoffman La Roche; and L’Oreal. The company was founded in 2007 and is headquartered in San Diego, California.

48 Employees
Last Reported Date: 06/10/14
Founded in 2007

organovo holdings inc (ONVO) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $82.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $67.6K
Chief Strategy Officer
Total Annual Compensation: $69.5K
Chief Technology Officer and Executive Vice P...
Total Annual Compensation: $67.6K
Executive Vice President of Commercial Operat...
Total Annual Compensation: $61.8K
Compensation as of Fiscal Year 2013.

organovo holdings inc (ONVO) Key Developments

Organovo Holdings, Inc.(AMEX:ONVO) added to Russell 2000 Index

Organovo Holdings, Inc. will be added to the Russell 2000 Index.

Organovo Holdings, Inc.(AMEX:ONVO) added to Russell 3000 Index

Organovo Holdings, Inc. will be added to the Russell 3000 Index.

Organovo Holdings, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 04:30 PM

Organovo Holdings, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 04:30 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ONVO:US $7.69 USD -0.46

ONVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advanced Cell Technology Inc $0.08 USD -0.0004
BioTime Inc $2.65 USD -0.08
Cytori Therapeutics Inc $2.21 USD -0.02
NeoStem Inc $5.86 USD -0.06
Osiris Therapeutics Inc $15.29 USD -0.30
View Industry Companies

Industry Analysis


Industry Average

Valuation ONVO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1,671.7x
Price/Book 13.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1,556.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORGANOVO HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at